Abstract
Background. A 44-year-old patient presented with intermittent macroscopic hematuria on a background of chronic left-sided hydronephrosis and intestinal metaplasia of the bladder. Cystoscopic examination revealed a mass at the dome of the urinary bladder, which was resected. Histopathologic analysis of the specimen confirmed the presence of muscle-invasive adenocarcinoma. Radical cystectomy with curative intent was planned, but review of systems and subsequent CT demonstrated pleural effusion with positive cytology, confirming metastatic disease. Owing to the histologic similarity between this patient's tumor and colorectal cancer, palliative FOLFOX6 (folinic acid, 5-fluorouracil and oxaliplatin) chemotherapy plus bevacizumab was administered. After 3 months of treatment the patient showed a good response, which was sustained for more than 10 months after diagnosis. However, his disease subsequently relapsed, and the patient died shortly thereafter.
Investigation. Physical examination, cystoscopy, transurethral resection of bladder tissue, CT, histopathologic, cytopathologic and immunohistochemical analysis.
Diagnosis. Metastatic adenocarcinoma of the urinary bladder.
Management. 12 cycles of infused and bolus 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX6) plus bevacizumab.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dahm, P. & Gschwend, J. E. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur. Urol. 44, 672–681 (2003).
Lughezzani, G. et al. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Urology 75, 376–381 (2010).
el-Mekresh, M. M., el-Baz, M. A., Abol-Enein, H. & Ghoneim, M. A. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br. J. Urol. 82, 206–212 (1998).
Siefker-Radtke, A. O. et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J. Urol. 169, 1295–1298 (2003).
Corica, F. A. et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology 50, 427–431 (1997).
Bullock, P. S., Thoni, D. E. & Murphy, W. M. The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer 59, 2086–2090 (1987).
Morton, M. J. et al. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin. Cancer Res. 13, 6232–6236 (2007).
Smith, A. K., Hansel, D. E. & Jones, J. S. Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma. Urology 71, 915–918 (2008).
Ghezala, W. et al. Re: intestinal metaplasia of the bladder. J. Urol. 176, 2309–2310 (2006).
Raspollini, M. R., Nesi, G., Baroni, G., Girardi, L. R. & Taddei, G. L. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl. Immunohistochem. Mol. Morphol. 13, 358–362 (2005).
Tamboli, P., Mohsin, S. K., Hailemariam, S. & Amin, M. B. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch. Pathol. Lab. Med. 126, 1057–1063 (2002).
Wang, H. L. et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am. J. Surg. Pathol. 25, 1380–1387 (2001).
Nevin, J. E. & Hoffman, A. A. Use of arterial infusion of 5-fluorouracil either alone or in combination with supervoltage radiation as a treatment for carcinoma of the prostate and bladder. Am. J. Surg. 130, 544–549 (1975).
Logothetis, C. J., Samuels, M. L. & Ogden, S. Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C. Urology 26, 252–255 (1985).
de Gramont, A. et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18, 2938–2947 (2000).
Saltz, L. B. et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J. Clin. Oncol. 26, 2013–2019 (2008).
Hahn, N. M. et al. A multicenter phase II study of cisplatin, gemcitabine, and bevacizumab as first-line chemotherapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU-0475 [abstract 5018]. J. Clin. Oncol. 27 (Suppl.), 15s (2009).
Tran, B. & McKendrick, J. Metastatic urachal cancer responding to FOLFOX chemotherapy. Can. J. Urol. 17, 5120–5123 (2010).
Author information
Authors and Affiliations
Contributions
All authors contributed equally to researching data, discussing content, writing and performing editing/review of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Teo, M., Swan, N. & McDermott, R. Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab. Nat Rev Urol 8, 282–285 (2011). https://doi.org/10.1038/nrurol.2011.48
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2011.48
This article is cited by
-
Therapiekonzepte für histologische Varianten und nichturotheliale Histologie von Blasentumoren
Die Onkologie (2022)
-
SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
Clinical and Translational Oncology (2022)
-
Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma
Modern Pathology (2017)
-
Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen
Medical Oncology (2012)